Search results for "mammary gland"

showing 10 items of 81 documents

O6-methylguanine-DNA methyltransferase activity in breast and brain tumors.

1995

The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) is a main determinant of resistance of tumor cells to the cytostatic activity of chemotherapeutic alkylating agents (methylating and chloroethylating nitrosoureas) and is effective in protecting normal cells against genotoxic and carcinogenic effects resulting from DNA alkylation. Therefore, the level of expression of MGMT is significant for the response of both the tumor and the non-target tissue following application of nitrosoureas in tumor therapy. To determine the expression of MGMT in tumor tissue, we have assayed MGMT activity in 68 breast carcinomas and 38 brain tumors. There was a wide variation of MGMT expression…

AdultMaleCancer ResearchPathologymedicine.medical_specialtyMethyltransferaseDNA RepairMammary glandBlotting WesternBreast NeoplasmsBiologyAstrocytomaO(6)-Methylguanine-DNA MethyltransferaseGliomaDNA Repair ProteinmedicineCarcinomaHumansneoplasmsCarcinogenAgedEpitheliomaL-Lactate DehydrogenaseBrain NeoplasmsAstrocytomaMethyltransferasesMiddle Agedmedicine.diseasedigestive system diseasesmedicine.anatomical_structureOncologyCancer researchFemaleGlioblastomaHeLa CellsInternational journal of cancer
researchProduct

Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis.

2006

To evaluate the association of dynamic enhancement parameters of benign and malignant breast lesions at magnetic resonance (MR) imaging with microvessel distribution and histologic prognostic tumor characteristics.Regional review board approval and informed consent were obtained. Surgical resection specimens of breast lesions (32 benign, 86 malignant) in 118 patients (age range, 28-86 years; mean, 58 years) who had undergone dynamic T1-weighted MR imaging of both breasts were included in the study. Different MR enhancement parameters and microvessel density (MVD) distribution were determined. In malignant lesions, TNM stage, tumor grade, proliferative activity, and hormone receptor expressi…

AdultMammary glandBreast NeoplasmsLesionsymbols.namesakemedicineCarcinomaHumansRadiology Nuclear Medicine and imagingStage (cooking)Lymph nodeMicrovesselFisher's exact testAgedAged 80 and overmedicine.diagnostic_testbusiness.industryMicrocirculationMagnetic resonance imagingMiddle Agedmedicine.diseasePrognosisMagnetic Resonance Imagingmedicine.anatomical_structuresymbolsmedicine.symptombusinessNuclear medicineRadiology
researchProduct

Transforming Growth Factor Beta 1 Serum Levels in Patients with Preinvasive and Invasive Lesions of the Breast

2004

Transforming growth factor beta (TGF-beta)1 is thought to be involved in breast carcinogenesis. TGF-beta1 acts in an antiproliferative manner in the early stages of breast carcinogenesis, but promotes tumor progression and metastases in the advanced stages of the disease. No data have been published on serum TGF-beta1 in breast cancer. We investigated TGF-beta1 serum levels in patients with breast cancer (n=135), ductal carcinoma in situ (DCIS) I to III (n=67) or fibroadenoma (n=35), and in healthy women (n=40) to determine its value as a differentiation marker between malignant, pre-invasive and benign diseases and as a predictive marker for metastatic spread. Median (range) TGF-beta1 seru…

AdultOncology0301 basic medicinemedicine.medical_specialtyPathologyCancer ResearchMammary glandClinical BiochemistryCA 15-3Breast NeoplasmsPathology and Forensic MedicineTransforming Growth Factor beta103 medical and health sciencesBreast cancer0302 clinical medicineTransforming Growth Factor betaInternal medicinemedicineHumansNeoplasm Invasivenessskin and connective tissue diseasesEstrogen Receptor StatusAgedNeoplasm StagingAged 80 and overPredictive markerbusiness.industryMiddle AgedDuctal carcinomamedicine.diseaseFibroadenomamedicine.anatomical_structure030104 developmental biologyOncologyTumor progression030220 oncology & carcinogenesisbusinessThe International Journal of Biological Markers
researchProduct

Morphea after silicone gel breast implantation for cosmetic reasons in an HLA-B8,DR3-positive woman

1997

We describe an HLA-B8, DR3-positive patient with localized morphea after silicone gel breast implantation for cosmetic reasons. We believe that this case suggests that a genetic background, i.e. HLA-B8, DR3 haplotype, is involved in the autoimmune response to silicone.

Adultmusculoskeletal diseasesmedicine.medical_specialtyBreast implantationBreast ImplantsMammaplastyImmunologyMammary glandCD4-CD8 RatioSiliconesHLA-B8 AntigenScleroderma Localizedchemistry.chemical_compoundHLA-DR3 AntigenSiliconeLocalized morpheamedicineHumansImmunology and AllergySurgery Plasticskin and connective tissue diseasesGlucocorticoidsbusiness.industrytechnology industry and agricultureGeneral Medicinemedicine.diseaseConnective tissue diseaseSurgeryPlastic surgerymedicine.anatomical_structurechemistryImmunologyPrednisoneFemalebusinessMorpheaCircumscribed scleroderma
researchProduct

Inhibition of liver trans-sulphuration pathway by propargylglycine mimics gene expression changes found in the mammary gland of weaned lactating rats…

2003

In the lactatingmammary gland, weaning produces mitochondrial cytochrome c release and nuclear DNA fragmentation, as determined by gel electrophoresis. This is followed by a significant decrease in lactation. Weaning for 2 h produces an early induction of the tumour suppressor/transcription factor p53, whereas the oncoprotein c-Jun and c-Jun N-terminal kinase are elevated after 24 h of weaning when compared with controls. The expression of p21cip1 and p27kip1, cyclin-dependent kinase inhibitors, was significantly higher in weaned rats when compared with control lactating rats. All the changes mentioned above also happen in the lactatingmammary gland when propargylglycine, an inhibitor of th…

BiochemistryAcetylcysteinechemistry.chemical_compoundLactationGene expressionGamma-glutamyltransferaseRegulation of gene expression:CIENCIAS DE LA VIDA::Bioquímica [UNESCO]biologyReverse Transcriptase Polymerase Chain ReactionCystathionine gamma-lyaseapoptosisgamma-Glutamyltransferaseglutathione (GSH)Glutathioneγ-cystathionasemedicine.anatomical_structureLiverAlkynesFemaleResearch Articlemedicine.drugmedicine.medical_specialtyGlycinel-cysteinelactationWeaningMammary Glands AnimalInternal medicinemedicineAnimalsLactationButhionine sulfoximineRats WistarButhionine SulfoximineMolecular BiologyDNA PrimersBase SequenceCystathionine gamma-LyaseUNESCO::CIENCIAS DE LA VIDA::BioquímicaCell BiologyGlutathioneAcetylcysteineRatsEndocrinologyGene Expression Regulationchemistrybiology.proteinSulfurBiochemical Journal
researchProduct

Calorie intake, olive oil consumption and mammographic density among Spanish women

2013

High mammographic density (MD) is one of the main risk factors for development of breast cancer. To date, however, relatively few studies have evaluated the association between MD and diet. In this cross-sectional study, we assessed the association between MD (measured using Boyd's semiquantitative scale with five categories: 75%) and diet (measured using a food frequency questionnaire validated in a Spanish population) among 3,548 peri- and postmenopausal women drawn from seven breast cancer screening programs in Spain. Multivariate ordinal logistic regression models, adjusted for age, body mass index (BMI), energy intake and protein consumption as well as other confounders, showed an asso…

Cancer ResearchCaloriemammographic densityCross-sectional studyWhite meatEpidemiologycalorie intakeBreast NeoplasmsBody Mass IndexBreast cancerRisk FactorsSurveys and QuestionnairesMedicineAnimalsHumansPlant OilsFood sciencebreast densityMammary Glands HumanMammographic densityOlive Oilbusiness.industryConfoundingOdds ratioFeeding BehaviorMiddle Agedmedicine.diseaseConfidence intervalDietCross-Sectional StudiesMilkOncologySpainBreast densityFemaleCalorie intakebusinessEnergy IntakeBody mass indexBiomarkersDemographyMammography
researchProduct

Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67.

1991

We performed immunohistochemical analyses of 568 breast/cancer specimens using Ki-67, a monoclonal antibody specific for a nuclear antigen present in proliferating cells. The specimens were divided into three groups (I-III) according to the proportion of Ki-positive cells detected. These findings were compared with features of tumor extension as well as with certain prognostic variables. There was no detectable correlation between Ki-67 reactivity and either tumor size or node involvement. In contrast, a statistically significant correlation was found between Ki-67 reactivity and tumor grading, in that G-I tumors had small growth fractions, while a high proportion of G-III tumors exhibited …

Cancer ResearchPrognostic variablePathologymedicine.medical_specialtymedicine.drug_classMammary glandBreast NeoplasmsMonoclonal antibodyBreast cancerAntigenmedicineBiomarkers TumorHumansbiologyCancerAntibodies Monoclonalmedicine.diseasePrognosismedicine.anatomical_structureOncologyKi-67biology.proteinImmunohistochemistryFemaleCell DivisionFollow-Up StudiesBreast cancer research and treatment
researchProduct

Ultrastructural evidence of collagenolytic activity in ductal infiltrating carcinoma of the human breast

1987

The stroma of ductal infiltrating carcinoma of the human breast shows characteristic and localized areas of collagen rarefaction and fragmentation. This finding has been correlated with a peculiar type of fibrillar damage, observed in a small percentage of collagen fibrils isolated in the native state from the tumour stroma. The same pattern of lesion has been reproduced in vitro by human collagenase digestion on reconstituted fibrils. No effect has been detected by other nonspecific proteases in the same system.

Cancer ResearchProteasesPathologymedicine.medical_specialtyMammary glandBreast Neoplasmsmacromolecular substancesBiologyLesionStromamedicineHumansTrypsinFragmentation (cell biology)AgedPancreatic ElastaseMiddle AgedIn vitroMicroscopy ElectronCarcinoma Intraductal NoninfiltratingMicrobial Collagenasemedicine.anatomical_structureOncologyCollagenaseUltrastructureFemaleCollagenmedicine.symptommedicine.drug
researchProduct

Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast?

2000

We studied the expression of oestrogen and progesterone receptors (ER, PR) in postmenopausal women receiving tamoxifen for breast cancer. In addition the literature addressing the question of ER and PR expression in breast tissue during treatment with tamoxifen was reviewed. We demonstrated consistent expression of ER and PR in endometria from patients receiving tamoxifen, with a trend towards a higher proportion of receptor positive specimens during tamoxifen. In breast cancer tissue, the ER content seemed to be reduced following tamoxifen treatment. After short time exposure to tamoxifen, the PR appeared to be increased, longer treatment caused the PR to go down to pretreatment levels or …

Cancer Researchmedicine.medical_specialtyAntineoplastic Agents Hormonalmedicine.drug_classMammary glandBreast NeoplasmsEndometriumEndometriumBreast cancerInternal medicineProgesterone receptormedicineHumansBreastskin and connective tissue diseasesbusiness.industryAntiestrogenmedicine.diseaseEndometrial NeoplasmsTamoxifenmedicine.anatomical_structureEndocrinologyOncologyReceptors EstrogenEstrogenImmunohistochemistryFemalebusinessReceptors Progesteronehormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method.

1994

To assess the possibility of substituting our routine method (dextran-coated charcoal, DCC) of determining estrogen (ER) and progesterone receptors (PR) for an enzyme immunoassay technique (EIA), we compared the two methods for determination of the two types of receptor in breast cancer specimens. In terms of sample positivity or negativity, the two techniques agreed in 76 of the 82 samples analyzed for ER (92.7%; p0.001), and in 65 out of 75 samples assayed for PR (86.6%; p0.001). Quantitative analysis of the data showed a significant correlation between DCC and EIA for both ER (r = 0.84; p0.0001) and PR (r = 0.77; p0.0001). The results suggest the usefulness of EIA in substituting DCC, al…

Cancer Researchmedicine.medical_specialtymedicine.drug_classMammary glandEstrogen receptorBreast NeoplasmsBiologyMonoclonal antibodyRadioligand AssayInternal medicineProgesterone receptormedicineRadioligandHumansReceptorfungiAntibodies MonoclonalGeneral MedicineRadioligand AssayEndocrinologymedicine.anatomical_structureOncologyReceptors EstrogenEstrogenFemaleReceptors Progesteronehormones hormone substitutes and hormone antagonistsOncology
researchProduct